While Flower remains the king when it comes to market share on LeafLink, Concentrates continue to grow in popularity according to market share, gaining 2.2% points from November to December to arrive at 16.6% overall market share. Concentrates are getting more popular with wholesale buyers. This month Flower was sold by just 30% of MO brands, but it made up 67% of all sales. December was the 5th straight month that Missouri contained both the most and least competitive product categories, as measured by the ratio of brands selling the category to the total percentage of category sales vs. There’s opportunity for Flower sellers in MO. This signals that demand is strong at the retailer level year-over-year, which can also be seen in the average transaction volume per buyer, which increased 9% month-over-month and 20% compared to December 2021. At a national level, retailers spent 20% more in December 2022 than the same period last year, and 50% of buyers increased their overall spend. Leaflink - January Flash Highlights: Everything you need to know. However, improving efficiency and lower costs in both cannabis retail and production might help Canadian cannabis companies stay afloat in a low-price environment. Canadian cannabis industry insiders say some level of continued price compression might remain on the horizon in 2022. The 2021 market data from Seattle-based cannabis data analytics firm Headset covers the province of Ontario, Canada’s largest market, the key Alberta and British Columbia markets as well as Saskatchewan. Retail prices for Canadian recreational cannabis products fell across the board in 2021, as retailers and producers sold them for less to entice price-sensitive consumers and capture market share. 1 if state officials took no action - after Hochul made the statewide rollout of retail marijuana shops a priority after taking office in August.Ĭanadian cannabis retail prices declined in 2021, led by vapes, concentrates.
Sources said MedMen appeared to want out of the deal and its relatively low price - whose terms were set to expire on Jan. Specifically, MedMen’s lawsuit alleges that Hochul’s office pushed regulators to approve the controversial deal after dragging their feet for nearly a year-and just days after one of Ascend’s executives attended a fundraiser for Hochul’s reelection campaign. Hochul’s administration used improper influence late last month to help recreational pot seller Ascend Wellness seal its $75M deal to buy the MedMen marijuana dispensary chain. Kathy Hochul’s office pushed to force the bargain-priced buyout of a well-positioned cannabis retailer just days before it was set to wriggle out of the deal - and just days after the lucky acquirer attended a fundraiser for Hochul, according to an explosive lawsuit. Hochul’s office pushed for $75M sale of MedMen to help campaign donor claims lawsuit. The ongoing shift is a welcome sign for the state’s struggling marijuana sector, which remains forbidden in the vast majority of California cities and, at the same time, must compete against a thriving illicit market. The rollout of new adult-use markets and business opportunities come as cities across the state are eager to bring in additional tax revenue after the pandemic and other factors depleted public coffers. Several other cities, meanwhile, are laying the groundwork for new markets down the road by drafting and/or developing cannabis ordinances. More than a dozen California cities are opening new recreational cannabis licensing opportunities this year, either by embracing the legal marijuana industry for the first time or by increasing the number of available business permits.
0 kommentar(er)
